Grant Sahag - GlyEco President CIO
| GLYEDelisted Stock | USD 0.0002 0.00 0.00% |
President
Mr. Grant Sahag is President Chief Executive Officer of the Company. He was appointed to the position of Chief Executive Officer of the Company. effective 1 May 2016. He was appointed as President on February 12 2016. Prior to being named as President Mr. Sahag served as Executive Vice President and Chief Information Officer of the Company. Prior to being named as Executive Vice President and Chief Information Officer Mr. Sahag served as Senior VP Business Development and VP International Development. Before joining the Company Mr. Sahag was a business attorney who specialized in providing strategic business development advice to emerging growth companies. Mr. Sahag managed a practice that focused in the areas of business formation corporate governance mergers and acquisitions intellectual property strategic partnerships and international development. Mr. Sahag past clients included technology startups retailers U.S. and international universities school districts nonprofit charities and professional athletes. Mr. Sahag has lead several international initiatives including the expansion of retail franchises into Mexico the development of a legal practice in Asia and supplychain logistics strategy for a nonprofit in Africa. Mr. Sahag received a Juris Doctor from Arizona State University specializing in business law and a B.S. in Business Administration from the University of Arizona. Mr. Sahag is President and Chairman of the nonprofit charity Success Through Sports. since 2016.
| Age | 30 |
| Tenure | 8 years |
| Phone | 866-960-1539 |
| Web | https://www.glyeco.com |
GlyEco Management Efficiency
The company has return on total asset (ROA) of (0.2076) % which means that it has lost $0.2076 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.9408) %, meaning that it created substantial loss on money invested by shareholders. GlyEco's management efficiency ratios could be used to measure how well GlyEco manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 2.78 M in liabilities with Debt to Equity (D/E) ratio of 786.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. GlyEco Inc has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist GlyEco until it has trouble settling it off, either with new capital or with free cash flow. So, GlyEco's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like GlyEco Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for GlyEco to invest in growth at high rates of return. When we think about GlyEco's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Steve Rooney | Sapiens International | N/A | |
| Stephen Falk | Cardinal Health | 49 | |
| Jake Newman | Teleflex Incorporated | N/A | |
| Liana Gelikas | Sapiens International | N/A | |
| Brian Rice | Cardinal Health | 57 | |
| Thomas Powell | Teleflex Incorporated | 62 | |
| Scott Palmer | Sapiens International | N/A | |
| Praneet Mehrotra | Teleflex Incorporated | N/A | |
| Mario Wijker | Teleflex Incorporated | 52 | |
| Lisa Kudlacz | Teleflex Incorporated | N/A | |
| Matthew James | Teleflex Incorporated | N/A | |
| Cameron Hicks | Teleflex Incorporated | 59 | |
| Karen Boylan | Teleflex Incorporated | 47 | |
| Patricia English | Cardinal Health | 44 | |
| James Leyden | Teleflex Incorporated | 52 | |
| James Ferguson | Teleflex Incorporated | N/A | |
| Leigh Vosseller | Tandem Diabetes Care | 50 | |
| Roger Graham | Teleflex Incorporated | N/A | |
| John Deren | Teleflex Incorporated | N/A | |
| Michele Holcomb | Cardinal Health | 52 | |
| Patricia Morrison | Cardinal Health | 58 | |
Management Performance
| Return On Equity | -13.94 | |||
| Return On Asset | -0.21 |
GlyEco Inc Leadership Team
Elected by the shareholders, the GlyEco's board of directors comprises two types of representatives: GlyEco inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GlyEco. The board's role is to monitor GlyEco's management team and ensure that shareholders' interests are well served. GlyEco's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GlyEco's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ian Rhodes, CFO | ||
| David Ide, CEO and President and Director | ||
| Grant Sahag, President CIO | ||
| Brian Gelman, Chief Officer | ||
| Charles Trapp, Director | ||
| Richard Opler, Independent Director | ||
| Alan Bender, VP Technology | ||
| Richard Geib, Chief Technical Officer | ||
| Scott Krinsky, Independent Director | ||
| Michael Olsson, Executive Vice President of Performance FluidsPerformance Fluids | ||
| Dwight Mamanteo, Director | ||
| Keri Smith, Independent Director | ||
| Frank Kneller, Director | ||
| Todd Smith, Executive VP of Sales | ||
| Michael Jaap, Independent Director | ||
| Scott Nussbaum, Independent Director | ||
| Michael Esq, Legal Consultant | ||
| Maria Tellez, Interim CFO and VP of Fin. | ||
| Dennis Kelly, Executive Vice President of Chemical Products | ||
| Jeremiah Hiller, Vice President - Sales & Marketing |
GlyEco Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is GlyEco a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.94 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (0.84) % | |||
| Operating Margin | (0.53) % | |||
| Current Valuation | 171.06 K | |||
| Shares Outstanding | 1.45 M | |||
| Price To Earning | (3.25) X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 6.93 M | |||
| Gross Profit | 1.29 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in GlyEco Pink Sheet
If you are still planning to invest in GlyEco Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GlyEco's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |